TOPIC

Biomedicine: Geopolitics

Related Topics:
Biomedicine: Geopolitics
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
last updated:
12 December, 2024
Wang Cunyu, a member of the US National Academy of Medicine, left China for the US in 1990. He has returned to develop Peking University’s Institute of Advanced Clinical Medicine. Photo: Handout
Science

China-born biologist Wang Cunyu returns from decades in US to head institute

Wang was recognised by Science magazine in 1996 for his work on cancer cell death.

videocam
43
US-China relations

Opinion | US-China science pact renewal a ray of hope amid techno-nationalism

videocam
SCMP Highlights

Recap | ‘Promising’ steps to HIV vaccine, Trump tariffs threaten profits: 5 biotech stories

Biomedicine: Companies

Chinese biotech firms brace for Trump tariffs, US funding bill

Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.

A robotic surgical system is displayed during the 2024 China Medical Equipment Conference in southwest China’s Chongqing Municipality on March 29, 2024. Photo: Xinhua
Biomedicine: Policy

Shanghai to back local biopharma firms’ overseas push, regulatory compliance

The initiative aims to generate about US$7 billion from medical product exports by 2027.

videocam
Wuxi AppTec

WuXi AppTec, WuXi Biologics rise in Hong Kong as some operations go up for sale

The gains were made on the back of a report that said the two firms plan to sell certain overseas operations amid heightened US scrutiny.

Advertisement
Advertisement
US-China relations

Opinion | Is biotech the next battleground in US-China decoupling?

With both countries viewing technological leadership as a zero-sum game, the risk of a fragmented global innovation ecosystem is growing.

videocam
Illustration: Craig Stephens
Science

China’s strides in academic research seen to narrow US lead in medical science

Growing momentum in research sets China up as a formidable player in future of global healthcare, according to scientific publishers.

videocam
39
China technology

China eyes sci-tech venture capital to boost industrial upgrade, economic growth

Premier Li Qiang said on Wednesday the development of venture capital is critical to sci-tech innovation, industrial upgrading and the growth of the economy.

Hong Kong stock market

US bill targets Chinese biotechs Wuxi AppTec, Wuxi Biologics

Shares of Wuxi AppTec and Wuxi Biologics fell after the US House passed a bill that would restrict business with Chinese biotech companies.

A Wuxi Biologics office. Photo: Wuxi Biologics
US-China relations

‘China Week’ bill restricting US contracts with Chinese biotech firms among first to pass

The congressional chamber began voting Monday on a series of bills to limit Beijing’s political, economic and technological influence.

11
A medical worker prepares a shot of Sinovac Biotech vaccine against the COVID-19 coronavirus disease at a community health station in Yantai, east China’s Shandong province, January 5, 2021. Photo: EPA-EFE
US-China relations

‘China week’ at US House puts biotech firms, Hong Kong offices in cross hairs

Most of the scheduled 28 items have bipartisan support and follow efforts to tackle national and economic security threats posed by Beijing.

videocam
19
China's economic recovery

Will medical tourists be the next to benefit from China’s visa-free push?

China is not generally considered a go-to option for healthcare and treatments, with the US, South Korea, Japan and Turkey already on the map.

videocam
8
Science

Who is on the growing list of China-linked scientists under US investigation?

The targeting of scientists in the United States for suspected Chinese ties reached a peak in 2018 and continues to affect a very altered research environment.

30
Many of the scientists accused by the US of having improper links with China were later cleared of wrongdoing. Shutterstock
Science

China Initiative left researchers feeling ‘targeted, alienated’, US agency says

The National Institutes of Health is taking steps to repair relations with Asian researchers, but damage is ‘long-lasting and almost irreversible’, scientist says.

videocam
62
The National Institutes of Health is the US government’s primary agency for biomedical and public health research. Photo: Shutterstock
Science

Foreign buyouts of Chinese drug firms spark national security fears

Some industry figures warn that sanctions could limit Chinese patients’ access to vital drugs after a series of takeovers by international firms.

videocam
6
US-China relations

Why US right-wing Project 2025 could be bad news for China if Trump wins

Heritage Foundation road map for a Trump-led government has its sights set on Beijing as it answers, ‘How we can take on China’.

videocam
63
Advertisement
Advertisement
US-China relations

US House panel approves bill limiting business with Chinese biotech firms

The bill would prevent federal agencies from contracting with five Chinese biotech companies – BGI Group, MGI, Complete Genomics, Wuxi AppTec, and Wuxi Biologics.

12
Drug research and development group WuXi AppTec and four other Chinese biotech companies are the target of new legislation a House committee passed 40-1 on Wednesday. Photo: Reuters
Banking & finance

Shanghai’s US$13.8 billion fund of funds to boost AI, semiconductor firms

Mainland China’s commercial and financial hub plans to set up a 100 billion yuan (US$13.8 billion) fund of funds focusing on key technology sectors to fire up the local economy.

Hong Kong society

Hong Kong scientists worry Biden’s order to block US data will hurt research

US action targeting ‘countries of concern’ may leave city’s researchers without access to critical data.

11
US-China relations

Time to ‘cut off’ US outbound investment in China biotech firms: House panel

Bipartisan support on show amid concern ‘every bit of value flowing’ to companies in the industry ‘will be used to strengthen the CCP and the PLA’.

videocam
20
Covid-19 testing in an inflatable lab provided by Chinese biotech firm, BGI Genomics, a subsidiary of BGI Group, in Beijing in 2020. US lawmakers have raised alarm over such companies’ reach in the American market. Photo: Xinhua via AP
Science

As China’s economy undergoes ‘structural upgrade’, tech becomes a top priority

That amounts to US$51.5 billion for 2024, with continued expenditure ‘guaranteed’ because of sector’s key role in driving development.

videocam
50
Science and technology has emerged as a priority area for Beijing. Photo: Shutterstock Images
Hong Kong stock market

US lawmaker moves to ban Chinese biotech firms from contracts on military link

The bill cites Chinese entities such as Third Military Medical University and Key Laboratory of High-Altitude Medicine as examples of ‘espionage tools’ of the Communist Party.

videocam
6
Medicine

China targets hi-tech drug and medical equipment industries for support

State Council unveils plans to promote development in the areas over the next two years.

videocam
9
US-China relations

The message in the US funding cut for China’s Wuhan Institute of Virology

The decision to suspend grants for the institute is symbolic of the dim prospects of US-China collaboration in the area, observers say.

videocam
62
The US has suspended the Wuhan Institute of Virology’s access to American federal funding. Photo: AFP
Semiconductors

Shanghai woos semiconductor and AI projects with generous subsidies

New policy is aimed at enhancing ‘vitality of industrial development’ and improving ‘city’s core competitiveness’.

Shanghai ups support of chips and AI sectors. Photo: Chinatopix via AP
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement